Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ascomycota | 4 | 2019 | 21 | 2.120 |
Why?
|
| Fusarium | 2 | 2022 | 11 | 1.400 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 432 | 0.950 |
Why?
|
| Plant Extracts | 2 | 2017 | 302 | 0.820 |
Why?
|
| Antifungal Agents | 3 | 2020 | 169 | 0.800 |
Why?
|
| Actinobacteria | 1 | 2020 | 14 | 0.650 |
Why?
|
| Molecular Structure | 6 | 2020 | 570 | 0.640 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 187 | 0.620 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 109 | 0.590 |
Why?
|
| Biological Products | 1 | 2020 | 91 | 0.580 |
Why?
|
| Candida albicans | 1 | 2020 | 176 | 0.580 |
Why?
|
| Isoquinolines | 1 | 2019 | 55 | 0.570 |
Why?
|
| Hawaii | 6 | 2022 | 2011 | 0.560 |
Why?
|
| Heliotropium | 1 | 2017 | 1 | 0.540 |
Why?
|
| Safrole | 1 | 2017 | 2 | 0.540 |
Why?
|
| Pyrones | 1 | 2017 | 11 | 0.540 |
Why?
|
| Lactams | 1 | 2017 | 10 | 0.540 |
Why?
|
| Xylariales | 1 | 2017 | 1 | 0.540 |
Why?
|
| Cyclohexanones | 1 | 2017 | 4 | 0.540 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 415 | 0.530 |
Why?
|
| Benzofurans | 1 | 2017 | 22 | 0.530 |
Why?
|
| Benzopyrans | 1 | 2017 | 25 | 0.530 |
Why?
|
| Sulfides | 1 | 2017 | 78 | 0.510 |
Why?
|
| Amides | 1 | 2017 | 71 | 0.510 |
Why?
|
| Pyridones | 1 | 2017 | 50 | 0.510 |
Why?
|
| Stress Fibers | 1 | 2016 | 4 | 0.510 |
Why?
|
| Acanthaceae | 1 | 2016 | 2 | 0.510 |
Why?
|
| Tight Junctions | 1 | 2016 | 27 | 0.500 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.490 |
Why?
|
| Phenols | 1 | 2017 | 107 | 0.490 |
Why?
|
| Sesquiterpenes | 1 | 2016 | 38 | 0.470 |
Why?
|
| Actins | 1 | 2016 | 164 | 0.470 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 134 | 0.470 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1455 | 0.460 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 92 | 0.450 |
Why?
|
| Fungi | 3 | 2022 | 106 | 0.450 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2019 | 301 | 0.400 |
Why?
|
| Endothelial Cells | 1 | 2016 | 329 | 0.400 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2020 | 245 | 0.370 |
Why?
|
| Inflammation | 2 | 2024 | 758 | 0.370 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 2676 | 0.360 |
Why?
|
| Diketopiperazines | 2 | 2022 | 5 | 0.310 |
Why?
|
| Neoplasms | 1 | 2019 | 1377 | 0.270 |
Why?
|
| Glucosides | 1 | 2024 | 21 | 0.220 |
Why?
|
| Protective Agents | 1 | 2024 | 26 | 0.220 |
Why?
|
| Fibroblasts | 1 | 2024 | 281 | 0.200 |
Why?
|
| Humans | 9 | 2024 | 43102 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2024 | 384 | 0.190 |
Why?
|
| Cell Survival | 3 | 2024 | 945 | 0.180 |
Why?
|
| Phenalenes | 1 | 2020 | 1 | 0.170 |
Why?
|
| Penicillium | 1 | 2020 | 6 | 0.170 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2020 | 8 | 0.170 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 94 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2019 | 99 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 458 | 0.140 |
Why?
|
| Cisplatin | 1 | 2019 | 98 | 0.140 |
Why?
|
| Shellfish Poisoning | 1 | 2017 | 4 | 0.140 |
Why?
|
| Primulaceae | 1 | 2017 | 1 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2024 | 1621 | 0.140 |
Why?
|
| Putrescine | 1 | 2017 | 27 | 0.130 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 21 | 0.130 |
Why?
|
| Pyrrolidinones | 1 | 2017 | 11 | 0.130 |
Why?
|
| Gram-Positive Bacteria | 1 | 2017 | 21 | 0.130 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 29 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2017 | 155 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2017 | 109 | 0.130 |
Why?
|
| Catechols | 1 | 2016 | 7 | 0.130 |
Why?
|
| Plant Components, Aerial | 1 | 2016 | 5 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 75 | 0.130 |
Why?
|
| Callyspongia | 1 | 2016 | 1 | 0.120 |
Why?
|
| Plants, Medicinal | 1 | 2016 | 57 | 0.120 |
Why?
|
| Phytotherapy | 1 | 2016 | 75 | 0.120 |
Why?
|
| Peptides, Cyclic | 1 | 2016 | 29 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 307 | 0.120 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 84 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2017 | 358 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2016 | 536 | 0.100 |
Why?
|
| Cell Line | 1 | 2017 | 1410 | 0.100 |
Why?
|
| Time Factors | 1 | 2016 | 1857 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1019 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2016 | 2157 | 0.060 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2024 | 26 | 0.060 |
Why?
|
| Skin | 1 | 2024 | 187 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 532 | 0.040 |
Why?
|
| Female | 1 | 2022 | 24698 | 0.040 |
Why?
|
| Acetaldehyde | 1 | 2020 | 11 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2020 | 93 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 506 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1003 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1124 | 0.030 |
Why?
|
| Costa Rica | 1 | 2016 | 9 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 127 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3735 | 0.020 |
Why?
|
| Animals | 2 | 2020 | 16992 | 0.020 |
Why?
|